Expression of extracellular matrix proteins in adenomatoid odontogenic tumor

Journal of Oral Pathology and Medicine

Volumn 39, Issue 3, 2010, Pages 230-235

  Modolo, Filipe ^a,b   Biz, Michelle Tillmann ^a   Martins, Marília Trierveiller ^b   MacHado De Sousa, Suzana Orsini ^b   De Araújo, Ney Soares ^b  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adenomatoid odontogenic tumor; Extracellular matrix; Immunohistochemistry

Indexed keywords

BIGLYCAN; BONE SIALOPROTEIN; DECORIN; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; SCLEROPROTEIN;

ADENOMATOID TUMOR; ARTICLE; CALCIFICATION; CARCINOGENESIS; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ODONTOGENIC TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

CALCINOSIS; CONNECTIVE TISSUE; CYTOPLASM; EPITHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ODONTOGENIC TUMORS; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; PROTEOGLYCANS; SIALOGLYCOPROTEINS;

EID: 77249144050     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00846.x     Document Type: Article

References (47)

1. Barnes L, Everson JW, Reichart P, et al. Odontogenic Tumours. In : Barnes L, Everson JW, Reichart P, Sidransky D eds. World Health Organization classification of tumours pathology and genetics of head and neck tumour. Lyon : IACR Press, 2005 283 327.
2. Alaeddini M, Etemad-Moghadam S, Baghaii F. Comparative expression of calretinin in selected odontogenic tumours: a possible relationship to histogenesis. Histopathology 2008 52 : 299 304.
3. Swasdison S, Dhanuthai K, Jainkittivong A, et al. Adenomatoid odontogenic tumors: an analysis of 67 cases in a Thai population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008 105 : 210 215.
4. Philipsen HP, Reichart PA, Siar CH, et al. An updated clinical and epidemiological profile of the adenomatoid odontogenic tumour: a collaborative retrospective study. J Oral Pathol Med 2007 36 : 383 393.
5. Philipsen HP, Nikai H. Adenomatoid odontogenic tumor. In : Barnes L, Everson JW, Reichart P, Sidransky D eds. World Health Organization classification of tumours pathology and genetics of head and neck tumour. Lyon : IACR Press, 2005 296 300.
6. Philipsen HP, Reichart PA. Adenomatoid odontogenic tumour: facts and figures. Oral Oncol 1999 35 : 125 131.
7. Ito Y, Abiko Y, Tanaka Y, et al. Immunohistochemical localization of large chondroitin sulfate proteoglycan in odontogenic tumor. Med Electron Microsc 2002 35 : 173 177.
8. Zhao M, Lu Y, Takata T, et al. Immunohistochemical and histochemical characterization of the mucosubstances of odontogenic myxoma: histogenesis and differential diagnosis. Pathol Res Pract 1999 195 : 391 397.
9. Hall RC, Embery G. The use of immunohistochemistry in understanding the structure and function of the extracellular matrix of dental tissues. Adv Dent Res 1997 11 : 478 486.
10. Martinez EF, Araujo VC. In vitro immunoexpression of extracellular matrix proteins in dental pulpal and gingival human fibroblasts. Int Endod J 2004 37 : 749 755.
11. Sommer B, Bickel M, Hofstetter W, et al. Expression of matrix proteins during the development of mineralized tissues. Bone 1996 19 : 371 380.
12. Tenório DMH, Santos MF, Zorn TMT. Distribution of biglycan and decorin in rat tissue. Braz J Med Biol Res 2003 36 : 1061 1065.
13. Goldberg M, Septier D, Rapoport O, et al. Biglycan is a repressor of amelogenin expression and enamel formation: an emerging hypothesis. J Dent Res 2002 81 : 520 524.
14. Boskey AL, Spevak L, Doty SB, et al. Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hidroxyapatite formation in a gelatin gel. Calcif Tissue Int 1997 61 : 298 305.
15. Vuillermoz B, Khoruzhenko A, D'onofrio MF, et al. The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp Cell Res 2004 296 : 294 306.
16. Leivo I, Jee KJ, Heikinheimo K, et al. Characterization of gene expression in major types of salivary gland carcinomas with epithelial differentiation. Cancer Genet Cytogenet 2005 156 : 104 113.
17. Köninger J, Giese T, Di Mola FF, et al. Pancreatic tumor cells influence the composition of the extracellular matrix. Biochem Biophys Res Commun 2004 322 : 943 949.
18. Embery G, Hall R, Waddington R, et al. Proteoglycans in dentinogenesis. Crit Rev Oral Biol Med 2001 12 : 331 349.
19. Yoshiba N, Yoshiba K, Iwaku M, et al. Immunolocalization of the small proteoglycan decorin in human teeth. Arch Oral Biol 1996 41 : 351 357.
20. Koninger J, Giese NA, Di Mola FF, et al. Overexpressed decorin in pancreatic cancer: potential tumor growth inhibition and attenuation of chemotherapeutic action. Clin Cancer Res 2004 10 : 4776 4783.
21. Termine JD, Kleinman HK, Whitson SW, et al. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 1981 26 : 99 105.
22. Ingram RT, Clarke BL, Fisher LW, et al. Distribution of noncollagenous proteins in the matrix of adult human bone: evidence of anatomic and functional heterogeneity. J Bone Miner Res 1993 8 : 1019 1029.
23. Robey PG. Vertebrate mineralized matrix proteins: structure and function. Connect Tissue Res 1996 35 : 131 136.
24. Boskey AL. Biomineralization: conflicts, challenges, and opportunities. J Cell Biochem Suppl 1998 31 : 83 91.
25. Lane TF, Sage EH. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 1994 8 : 163 173.
26. Rempel SA, Ge S, Gutierrez JA. SPARC: a potential diagnostic marker of invasive meningiomas. Clin Cancer Res 1999 5 : 237 241.
27. Sasano Y, Zhu JX, Kamakura S, et al. Expression of major bone extracellular matrix proteins during embryonic osteogenesis in rat mandibles. Anat Embryol (Berl) 2000 202 : 31 7.
28. Fisher LW, Fedarko NS. Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res 2003 44 : 33 40.
29. Muramatsu T, Shima K, Ohta K, et al. Inhibition of osteopontin expression and function in oral cancer cell lines by antisense oligonucleotides. Cancer Lett 2005 217 : 87 95.
30. Cogan G, Bansal AK, Ibrahim S, et al. Analysis of human bone sialoprotein in normal and pathological tissues using a monoclonal antibody (BSP 1.2 mab). Connect Tissue Res 2004 45 : 60 71.
31. Faccio R, Grano M, Colucci S, et al. Localization and possible role of two different alpha v beta 3 integrin conformations in resting and resorbing osteoclasts. J Cell Sci 2002 115 : 2919 2929.
32. Ibrahim T, Leong I, Sanchez-Sweatman O, et al. Expression of bone sialoprotein and osteopontin in breast cancer bone metastases. Clin Exp Metastasis 2000 18 : 253 260.
33. Ohma N, Takagi Y, Takano Y. Distribution of non-collagenous dentin matrix proteins and proteoglycans, and their relation to calcium accumulation in bisphosphonate-affected rat incisors. Eur J Oral Sci 2000 108 : 222 232.
34. Sulzbacher I, Birner P, Trieb K, et al. Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors. Virchows Arch 2002 441 : 345 349.
35. Ganss B, Kim RH, Sodek J. Bone sialoprotein. Crit Rev Biol Med 1999 10 : 79 98.
36. Ducy P, Karsenty G. Skeletal gla proteins: gene structure, regulation of expression, and function. In : Bilezikian JP, Raisz LD, Rondan GA eds. Principles of bone biolog. San Diego : Academic Press, 1996 183 195.
37. Schaefer L, Grone H-J, Raslik I, et al. Small proteoglycans of normal adult human kidney: Distinct expression patterns of decorin, biglycan, fibromodulin, and lumican. Kidney Int 2000 58 : 1557 1568.
38. Modolo F, Martins MT, Loducca SVL, et al. Expression of integrin subunits alpha2, alpha 3, alpha 5, alpha V, beta1, beta3, beta4 in different histological types of ameloblastoma compared with dental germ, dental lamina and adult lining epithelium. Oral Dis 2004 10 : 277 282.
39. Banerjee AG, Bhattacharyya I, Lydiatt WM, et al. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. Cancer Res 2003 63 : 7769 7776.
40. Papagerakis P, Peuchmaur M, Hotton D, et al. Aberrant gene expression in epithelial cells of mixed odontogenic tumors. J Dent Res 1999 78 : 20 30.
41. Murata M, Cheng J, Horino K, et al. Enamel proteins and extracellular matrix molecules are co-localized in the pseudocystic stromal space of adenomatoid odontogenic tumor. J Oral Pathol Med 2000 29 : 483 490.
42. Philipsen HP, Reichart PA. Revision of the 1992-edition of the WHO histological typing of odontogenic tumours. A suggestion. J Oral Pathol Med 2002 31 : 253 258.
43. Saku T, Okabe H, Shimokawa H. Immunohistochemical demonstration of enamel proteins in odontogenic tumors. J Oral Pathol Med 1992 21 : 113 119.
44. Mori M, Yamada K, Kasai T, et al. Immunohistochemical expression of amelogenins in odontogenic epithelial tumours and cysts. Virchows Arch A Pathol Anat Histopathol 1991 418 : 319 325.
45. Ständer M, Naumann U, Wick W, et al. Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res 1999 296 : 221 227.
46. Zanotti S, Negri T, Cappelletti C, et al. Decorin and biglycan expression is differentially altered in several muscular dystrophies. Brain 2005 128 : 2546 2555.
47. Poomsawat S, Punyasingh J, Vejchapipat P. Expression of basement membrane components in odontogenic tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 104 : 666 675.